• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

基于电子药效团的 mGluR5 负变构调节剂筛选用于中枢神经系统疾病。

E-pharmacophore-based screening of mGluR5 negative allosteric modulators for central nervous system disorder.

机构信息

Computer Aided Drug Designing and Molecular Modeling Laboratory, Department of Bioinformatics, Alagappa University, Karaikudi, Tamil Nadu 630 004, India.

Computer Aided Drug Designing and Molecular Modeling Laboratory, Department of Bioinformatics, Alagappa University, Karaikudi, Tamil Nadu 630 004, India.

出版信息

Comput Biol Chem. 2019 Feb;78:414-423. doi: 10.1016/j.compbiolchem.2018.12.016. Epub 2018 Dec 26.

DOI:10.1016/j.compbiolchem.2018.12.016
PMID:30621985
Abstract

Glutamate, a major neurotransmitter in the central nervous system of human, plays a crucial role in various neurological pathways by activating the ligand-gated ion channels such as mGluR and iGluR. Dysfunction of mGluR 5 can cause Alzheimer's disease, Parkinson's disease, epilepsy, depression, anxiety, etc. In the current study, we have developed the energetically optimized pharmacophore model to screen the eMolecules database having more than 6 million compounds with the help of reported cocrystal structure with 3-chloro-5-[6-(5-fluoropyridin-2 yl)pyrimidin-4-yl]benzonitrile (PDB ID: 5CGD). The obtained hits were docked into the allosteric site of the target and further validation of E-pharmacophore was done by enrichment calculations followed by the molecular dynamics simulations to analyze the specific amino acid interactions with the compound present in the allosteric site of the receptor.

摘要

谷氨酸是人类中枢神经系统中的一种主要神经递质,通过激活配体门控离子通道(如 mGluR 和 iGluR),在各种神经通路中发挥着关键作用。mGluR5 的功能障碍可导致阿尔茨海默病、帕金森病、癫痫、抑郁、焦虑等。在本研究中,我们开发了能量优化的药效团模型,借助与 3-氯-5-[6-(5-氟吡啶-2-基)嘧啶-4-基]苯甲腈(PDB ID:5CGD)的报道共晶结构,对 eMolecules 数据库中超过 600 万个化合物进行筛选。获得的命中化合物与靶标变构位点对接,并通过富集计算进一步验证 E-药效团,随后进行分子动力学模拟以分析与受体变构位点中化合物相互作用的特定氨基酸。

相似文献

1
E-pharmacophore-based screening of mGluR5 negative allosteric modulators for central nervous system disorder.基于电子药效团的 mGluR5 负变构调节剂筛选用于中枢神经系统疾病。
Comput Biol Chem. 2019 Feb;78:414-423. doi: 10.1016/j.compbiolchem.2018.12.016. Epub 2018 Dec 26.
2
Identification of Potential Dual Negative Allosteric Modulators of Group I mGluR Family: A Shape Based Screening, ADME Prediction, Induced Fit Docking and Molecular Dynamics Approach Against Neurodegenerative Diseases.基于形状的筛选、ADME 预测、诱导契合对接和分子动力学方法鉴定 I 型 mGluR 家族的潜在双阴性变构调节剂:针对神经退行性疾病。
Curr Top Med Chem. 2019;19(29):2687-2707. doi: 10.2174/1568026619666191105112800.
3
Atom-based 3D-QSAR, induced fit docking, and molecular dynamics simulations study of thieno[2,3-b]pyridines negative allosteric modulators of mGluR5.基于原子的3D-QSAR、诱导契合对接以及对代谢型谷氨酸受体5(mGluR5)的噻吩并[2,3-b]吡啶负变构调节剂的分子动力学模拟研究
J Recept Signal Transduct Res. 2018 Jun;38(3):225-239. doi: 10.1080/10799893.2018.1476542. Epub 2018 May 28.
4
Energetically optimized pharmacophore modeling to identify dual negative allosteric modulators against group I mGluRs in neurodegenerative diseases.基于能量优化的药效团模型,鉴定神经退行性疾病中 I 型 mGluRs 的双负变构调节剂。
J Biomol Struct Dyn. 2020 May;38(8):2326-2337. doi: 10.1080/07391102.2019.1640794. Epub 2019 Aug 8.
5
Interaction of novel positive allosteric modulators of metabotropic glutamate receptor 5 with the negative allosteric antagonist site is required for potentiation of receptor responses.代谢型谷氨酸受体5新型正变构调节剂与负变构拮抗剂位点的相互作用是增强受体反应所必需的。
Mol Pharmacol. 2007 May;71(5):1389-98. doi: 10.1124/mol.106.032425. Epub 2007 Feb 15.
6
Neurophysiological signals as potential translatable biomarkers for modulation of metabotropic glutamate 5 receptors.神经生理信号作为调节代谢型谷氨酸受体5的潜在可转化生物标志物。
Neuropharmacology. 2013 Dec;75:19-30. doi: 10.1016/j.neuropharm.2013.06.020. Epub 2013 Jul 4.
7
Synthesis and optimization of 4,5,6,7-tetrahydrooxazolo[4,5-c]pyridines as potent and orally-active metabotropic glutamate receptor 5 negative allosteric modulators.4,5,6,7-四氢恶唑并[4,5-c]吡啶作为强效口服活性代谢型谷氨酸受体5负变构调节剂的合成与优化
Bioorg Med Chem Lett. 2017 Sep 15;27(18):4331-4335. doi: 10.1016/j.bmcl.2017.08.030. Epub 2017 Aug 16.
8
Insights into the interaction of negative allosteric modulators with the metabotropic glutamate receptor 5: discovery and computational modeling of a new series of ligands with nanomolar affinity.对负变构调节剂与代谢型谷氨酸受体5相互作用的深入研究:发现及对一系列具有纳摩尔亲和力的新型配体的计算建模
Bioorg Med Chem. 2015 Jul 1;23(13):3040-58. doi: 10.1016/j.bmc.2015.05.008. Epub 2015 May 12.
9
7TM X-ray structures for class C GPCRs as new drug-discovery tools. 1. mGluR5.用于C类G蛋白偶联受体的7TM X射线结构作为新型药物发现工具。1. 代谢型谷氨酸受体5
Bioorg Med Chem Lett. 2016 Jan 15;26(2):484-494. doi: 10.1016/j.bmcl.2015.11.087. Epub 2015 Nov 25.
10
Fragment and Structure-Based Drug Discovery for a Class C GPCR: Discovery of the mGlu5 Negative Allosteric Modulator HTL14242 (3-Chloro-5-[6-(5-fluoropyridin-2-yl)pyrimidin-4-yl]benzonitrile).基于片段和结构的C类G蛋白偶联受体药物发现:代谢型谷氨酸受体5负变构调节剂HTL14242(3-氯-5-[6-(5-氟吡啶-2-基)嘧啶-4-基]苯甲腈)的发现
J Med Chem. 2015 Aug 27;58(16):6653-64. doi: 10.1021/acs.jmedchem.5b00892. Epub 2015 Aug 12.

引用本文的文献

1
Metabotropic glutamate receptors (mGluRs) in epileptogenesis: an update on abnormal mGluRs signaling and its therapeutic implications.代谢型谷氨酸受体(mGluRs)在癫痫发生中的作用:mGluRs异常信号传导及其治疗意义的最新进展
Neural Regen Res. 2024 Feb;19(2):360-368. doi: 10.4103/1673-5374.379018.
2
Discovery of novel TMPRSS2 inhibitors for COVID-19 using fragment-based drug design, molecular docking, molecular dynamics, and quantum mechanics studies.利用基于片段的药物设计、分子对接、分子动力学和量子力学研究发现新型新冠病毒跨膜丝氨酸蛋白酶2(TMPRSS2)抑制剂
Inform Med Unlocked. 2022;29:100870. doi: 10.1016/j.imu.2022.100870. Epub 2022 Feb 2.
3
The role of water and protein flexibility in the structure-based virtual screening of allosteric GPCR modulators: an mGlu receptor case study.
水和蛋白质柔性在变构 GPCR 调节剂基于结构的虚拟筛选中的作用:mGlu 受体案例研究。
J Comput Aided Mol Des. 2019 Sep;33(9):787-797. doi: 10.1007/s10822-019-00224-w. Epub 2019 Sep 21.
4
Computational Drug Design Applied to the Study of Metabotropic Glutamate Receptors.计算药物设计在代谢型谷氨酸受体研究中的应用。
Molecules. 2019 Mar 20;24(6):1098. doi: 10.3390/molecules24061098.